Dietary enrichment of apolipoprotein E-deficient mice with extra virgin olive oil in combination with seal oil inhibits atherogenesis

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Eilertsen, Karl Erik ^a   Mæhre, Hanne K ^a   Cludts, Katrien ^b   Olsen, Jan O ^a,c   Hoylaerts, Marc F ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c HERG   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CORN OIL; EDIBLE OIL; EXTRA VIRGIN OLIVE OIL; OLIVE OIL; SEAL OIL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CHOLESTEROL; OMEGA 3 FATTY ACID; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ARCH; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; FEMALE; HYPERLIPOPROTEINEMIA TYPE 3; LIPID DIET; MALE; MOUSE; NONHUMAN; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ANIMAL; ATHEROSCLEROSIS; BLOOD; MEDITERRANEAN DIET; PATHOLOGY; PATHOPHYSIOLOGY;

MUS; ZEA MAYS;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; DIET, MEDITERRANEAN; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; HYPERLIPOPROTEINEMIA TYPE III; MALE; MICE; PLANT OILS; TRIGLYCERIDES;

EID: 79952100135     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-41     Document Type: Article

References (32)

1. Olive oil and cardiovascular health. MI Covas V Konstantinidou M Fitá J Cardiovasc Pharmacol 2009 54 477 482 10.1097/FJC.0b013e3181c5e7fd 19858733
2. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study. M de Lorgeril P Salen JL Martin I Monjaud J Delaye N Mamelle, Circulation 1999 99 779 785 9989963 (Pubitemid 29083018)
3. Adherence to the Mediterranean Diet and Risk of Coronary Heart Disease in the Spanish EPIC Cohort Study. G Buckland CA Gonzlez A Agudo M Vilardell A Berenguer P Amiano E Ardanaz L Arriola A Barricarte M Basterretxea MD Chirlaque L Cirera M Dorronsoro N Egües JM Huerta N Larrãaga P Marin C Martínez E Molina C Navarro JR Quirás L Rodriguez MJ Sanchez MJ Tormo C Moreno-Iribas, Am J Epidemiol 2009 170 1518 1529 10.1093/aje/kwp282 19903723
4. Adherence to a Mediterranean diet and survival in a Greek population. A Trichopoulou T Costacou C Bamia D Trichopoulos, N Engl J Med 2003 348 2599 2608 10.1056/NEJMoa025039 12826634 (Pubitemid 36741587)
5. Minor Components of Olive Oil: Evidence to Date of Health Benefits in Humans. MI Covas V Ruiz-Gutiérrez R de la Torre A Kafatos RM Lamuela-Raventás J Osada RW Owen F Visioli, Nutr Rev 2006 64 1 S11 10.1301/nr.2006.oct.S20-S30 (Pubitemid 44606850)
6. Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Cárdoba (Spain) 2008. J Lápez-Miranda F Pérez-Jiménez E Ros R De Caterina L Badimán MI Covas E Escrich JM Ordovs F Soriguer R Abi CA de la Lastra M Battino D Corella J Chamorro-Quirás J Delgado-Lista D Giugliano K Esposito R Estruch JM Fernandez-Real JJ Gaforio C La Vecchia D Lairon F Lápez-Segura P Mata JA Menéndez FJ Muriana J Osada DB Panagiotakos JA Paniagua P Pérez-Martinez J Perona MA Peinado M Pineda-Priego HE Poulsen JL Quiles MC Ramírez-Tortosa J Ruano L Serra-Majem R Sol M Solanas V Solfrizzi R de la Torre-Fornell A Trichopoulou M Uceda JM Villalba-Montoro JR Villar-Ortiz F Visioli N Yiannakouris, Nutr Metab Cardiovasc Dis 2010 20 284 94 20303720
7. Cardiovascular risk factors in Inuit of Greenland. P Bjerregaard G Mulvad HS Pedersen, Int J Epidemiol 1997 26 1182 1190 10.1093/ije/26.6.1182 9447397 (Pubitemid 28010435)
8. Effects of dietary marine oils and olive oil on fatty acid composition, platelet membrane fluidity, platelet responses, and serum lipids in healthy humans. E Vognild EO Elvevoll J Brox RL Olsen H Barstad M Aursand B sterud, Lipids 1998 33 427 436 10.1007/s11745-998-0224-8 9590631 (Pubitemid 28217389)
9. The combination of virgin olive oils and refined marine oils. Beneficial effects. B sterud EO Elvevoll, Progr Nutr 2008 10 230 236
10. Severe Hypercholesterolemia and Atherosclerosis in Apolipoprotein-E- Deficient Mice Created by Homologous Recombination in Es Cells. AS Plump JD Smith T Hayek K Aaltosetala A Walsh JG Verstuyft EM Rubin JL Breslow, Cell 1992 71 343 353 10.1016/0092-8674(92)90362-G 1423598
11. Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein-E. SH Zhang RL Reddick JA Piedrahita N Maeda, Science 1992 258 468 471 10.1126/science.1411543 1411543
12. Enhanced incorporation of n-3 fatty acids from fish compared with fish oils. EO Elvevoll H Barstad ES Breimo J Brox KE Eilertsen T Lund JO Olsen B sterud, Lipids 2006 41 1109 1114 10.1007/s11745-006-5060-3 17269556 (Pubitemid 46095223)
13. Methods for measuring autoxidation resistance. KE Larsen, Proceedings of the 15th Scandinavian symposium on lipids Lipidforum. Rebild Bakker Denmark 1989
14. Effect of Marine Oils Supplementation on Coagulation and Cellular Activation in Whole-Blood. B sterud E Elvevoll H Barstad J Brox H Halvorsen K Lia JO Olsen RL Olsen C Sissener Rekdal E Vognild, Lipids 1995 30 1111 1118 8614301
15. Emerging role of estrogen in the control of cardiometabolic disease. A Cignarella M Kratz C Bolego, Trends Pharmacol Sci 2010 31 183 189 10.1016/j.tips.2010.01.001 20138672
16. Heat Shock Protein 27 Protects Against Parthenogenesis via an Estrogen-Dependent Mechanism: Role of Selective Estrogen Receptor Beta Modulation. K Rayner J Sun YX Chen M McNulty T Simard X Zhao J Wells Belleroche ER O'Brien, Arterioscler Thromb Vasc Biol 2009 29 1751 1756 10.1161/ATVBAHA.109. 193656 19729610
17. 2and decreased prostacyclin production. DD Smith X Tan G Milne DJ Stechschulte KN Dileepan, J Physiol Pharmacol 2010 61 309 316 20610861
18. Gender-specific inhibition of platelet aggregation following omega-3 fatty acid supplementation. M Phang AJ Sinclair LF Lincz ML Garg, Nutr Metab Cardiovasc Dis 2010 20708391
19. Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. P Bogani C Galli M Villa F Visioli, Atherosclerosis 2007 190 181 186 10.1016/j.atherosclerosis.2006.01.011 16488419 (Pubitemid 44908313)
20. Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. F Visioli G Bellomo G Montedoro C Galli, Atherosclerosis 1995 117 25 32 10.1016/0021-9150(95)05546-9 8546752
21. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. MI Covas K Nyyssönen HE Poulsen J Kaikkonen HJ Zunft H Kiesewetter A Gaddi R de la Torre J Mursu H Bäumler S Nascetti JT Salonen M Fitá J Virtanen J Marrugat EUROLIVE Study Group, Ann Intern Med 2006 145 333 341 16954359 (Pubitemid 46768590)
22. Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: enhanced macrophage cholesterol efflux. M Rosenblat N Volkova R Coleman Y Almagor M Aviram, J Nutr Biochem 2008 19 514 523 10.1016/j.jnutbio.2007.06.007 17904345 (Pubitemid 351952321)
23. The relationship between the fatty acid composition of immune cells and their function. PC Calder, Prostaglandins Leukot Essent Fatty Acids 2008 79 101 108 10.1016/j.plefa.2008.09.016 18951005
24. Protection of atherogenesis in thromboxane A2 receptor-deficient mice is not associated with thromboxane A2 receptor in bone marrow-derived cells. X Zhuge H Arai Y Xu T Murayama T Kobayashi S Narumiya T Kita M Yokode, Biochem Biophys Res Commun 2006 351 865 871 10.1016/j.bbrc.2006.10.121 17097058 (Pubitemid 44715865)
25. Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signalling pathway. D Richard C Wolf U Barbe K Kefi P Bausero F Visioli, Biochem Biophys Res Commun 2009 389 516 522 10.1016/j.bbrc.2009.09.013 19737538
26. Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment. EA Heller E Liu AM Tager S Sinha JD Roberts SL Koehn P Libby ER Aikawa JQ Chen P Huang MW Freeman KJ Moore AD Luster RE Gerszten, Circulation 2005 112 578 586 10.1161/CIRCULATIONAHA.105. 545616 16043658 (Pubitemid 41060799)
27. Docosapentaenoic acid (22:5n-3): A review of its biological effects. G Kaur D Cameron-Smith M Garg AJ Sinclair, Prog Lipid Res 2010 50 28 34 10.1016/j.plipres.2010.07.004 20655949
28. Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. GK Beauchamp RS Keast D Morel J Lin J Pika Q Han CH Lee AB Smith PA Breslin, Nature 2005 437 45 46 10.1038/437045a 16136122 (Pubitemid 41613421)
29. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. M Mehrabian H Allayee J Wong WB Shih XP Wang Z Shaposhnik CD Funk AJ Lusis, Circ Res 2002 91 120 126 10.1161/01.RES.0000028008.99774.7F 12142344 (Pubitemid 34827222)
30. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice - Evidence that eicosanoids other than thromboxane contribute to atherosclerosis. AJ Cayatte Y Du J Oliver-Krasinski G Lavielle TJ Verbeuren RA Cohen, Arterioscler Thromb Vasc Biol 2000 20 1724 28 10894809 (Pubitemid 30470586)
31. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. F Thies JM Garry P Yaqoob K Rerkasem J Williams CP Shearman PJ Gallagher PC Calder RF Grimble, Lancet 2003 361 477 485 10.1016/S0140-6736(03)12468-3 12583947 (Pubitemid 36173713)
32. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. AL Cawood R Ding FL Napper RH Young JA Williams MJ Ward O Gudmundsen R Vige SP Payne S Ye CP Shearman PJ Gallagher RF Grimble PC Calder, Atherosclerosis 2010 212 252 259 10.1016/j.atherosclerosis.2010.05.022 20542512